medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Número 2

<< Anterior Siguiente >>

Rev Invest Clin 2016; 68 (2)


Aging Kidney Transplantation

Musso CG, Giordani MC, Imperiali N

Idioma: Ingles.
Referencias bibliográficas: 38
Paginas: 68-74
Archivo PDF: 80.65 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Li P, Tian C, Ge N, et al. Premature senescence of T cells in longterm survivors of renal transplantation. Biochem Biophys Res Commun. 2011;407:599-604.

  2. See comment in PubMed Commons belowTekin S, Yavuz HA, Yuksel Y, et al. Kidney transplantation from elderly donor. Transplant Proc. 2015;47:1309-11.

  3. Joosten SA, van Ham V, Nolan CE, et al. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol. 2003;162:1305-12.

  4. Heinbokel T, Hock K, Liu G, Edtinger K, Elkhal A, Tullius SG. Impact of immunosenescence on transplant outcome. Transpl Int. 2013;26:242-53.

  5. Musso CG. Geriatric nephrology and the ‘nephrogeriatric giants’. Int Urol Nephrol. 2002;34:255-6.

  6. Melk A, Schmidt BM, Braun H, et al. Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant. 2009;9:114-23.

  7. Arvizu-Hernández M, Morales-Buenrostro LE, Vilatoba-Chapa M, et al. Time of occurrence of kidney acute antibody-mediated allograft rejection/acute cellular rejection and cell senescence: implications for function outcome. Transplant Proc. 2010;42:2486-92.

  8. Liu S, Lutz J, Antus B, et al. Recipient age and weight affect chronic renal allograft rejection in rats. J Am Soc Nephrol. 2001; 12:1742-9.

  9. de Fijter JW. The impact of age on rejection in kidney transplantation. Drugs Aging. 2005;22:433-49.

  10. Melk A, Schmidt BM, Vongwiwatana A, Rayner DC, Halloran PF. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant. 2005;5:1375-82.

  11. Yoon HE, Ghee JY, Piao S, et al. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant. 2011;26:800-13.

  12. Sugiura H, Yoshida T, Mitobe M, et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant. 2010;25:60-8.

  13. Han DH, Piao SG, Song JH, et al. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. Transplantation. 2010;90:135-41.

  14. Tataranni T, Biondi G, Cariello M, et al. Rapamycin-induced hypophosphatemia and insulin resistance are associated with mTORC2 activation and Klotho expression. Am J Transplant. 2011;11:1656-64.

  15. Buemi M, Nostro L, Aloisi C, Cosentini V, Criseo M, Frisina N. Kidney aging: from phenotype to genetics. Rejuvenation Res. 2005;8:101-9.

  16. Sugiura H, Yoshida T, Tsuchiya K, et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant. 2005;20:2636-45.

  17. Doma ski L, Kłoda K, Kwiatkowska E, et al. Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study. BMC Nephrol. 2015;16:23.

  18. Cagigi A, Rinaldi S, Santilli V, et al. Premature ageing of the immune system relates to increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1-infected and kidney-transplanted patients. Clin Exp Immunol. 2013;174:274-80.

  19. Sahin E, Colla S, Liesa M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470:359-65.

  20. Sugden MC, Caton PW, Holness MJ. PPAR control: It’s SIRTainly as easy as PGC. J Endocrinol. 2010;204:93-104.

  21. Herranz D, Muñoz-Martin M, Cañamero M, et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun. 2010;1:3.

  22. He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010; 120:1056-68.

  23. Perico N, Remuzzi G, Benigni A. Aging and the kidney. Curr Opin Nephrol Hypertens. 2011;20:312-7.

  24. Cassis P, Conti S, Remuzzi G, Benigni A. Angiotensin receptors as determinants of life span. Pflugers Arch. 2010;459:325-32.

  25. Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L, Williams B. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res. 2008;102:201-8.

  26. Abadir PM, Foster DB, Crow M, et al. Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci U S A. 2011;108:14849-54.

  27. Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest. 2009; 119:524-30.

  28. Chkhotua AB, Abendroth D, Froeba G, Schelzig H. Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time. Transpl Int. 2006;19:72-7.

  29. Furuzawa-Carballeda J, Lima G, Alberú J, et al. Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A. Clin Exp Immunol. 2012;167:330-7.

  30. Trzonkowski P, Debska-Slizie A, Jankowska M, et al. Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells. Mech Ageing Dev. 2010;131:96-104.

  31. McKay D, Jameson J. Kidney transplantation and the ageing immune system. Nat Rev Nephrol. 2012;8:700-8.

  32. Jiménez R, Carracedo J, Ramírez R, del Castillo D, Pérez R, Aljama AP. Acute renal rejection is associated with induction of replicative senescence in CD8+ T lymphocytes. Nefrologia. 2006;26:609-14.

  33. Meijers RW, Betjes MG, Baan CC, Litjens NH. T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance. World J Nephrol. 2014;3:268-76.

  34. Coppedè F. The epidemiology of premature aging and associated comorbidities. Clin Interv Aging. 2013;8:1023-32.

  35. Sinha JK, Ghosh S, Raghunath M. Progeria: a rare genetic premature ageing disorder. Indian J Med Res. 2014;139:667-74.

  36. Jennings P, Koppelstaetter C, Aydin S, et al. Cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol. 2007;293:F831-8.

  37. FNankivell BJ. Importance of age in evolving graft histology. Transplantation. 2007;83:682.

  38. Tullius SG, Milford E. Kidney allocation and the aging immune response. N Engl J Med. 2011;364:1369-70.




2020     |     www.medigraphic.com